Argenica rat brain study shows potential neuroprotective action in ARG-007
Argenica Therapeutics (ASX:AGN) is reporting a rat study of its traumatic brain…
Argenica Therapeutics Limited (ASX:AGN)
About Argenica Therapeutics Limited
Key Information
AGN In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 21/03/2025 | Change of Share Registry Details | 172.43KB | 253 |
| 12/03/2025 | Investor Presentation | 2.34MB | 8.0K |
| 03/03/2025 | Final Director's Interest Notice | 284.27KB | 233 |
| 03/03/2025 | Non-Executive Director Resignation | 187.11KB | 4.3K |
| 11/02/2025 | Price Sensitive PS Half Yearly Report and Accounts | 622.94KB | 498 |
| 04/02/2025 | Price Sensitive PS Updated - Main TBI Injury Study Annoucement | 479.14KB | 459 |
| 04/02/2025 | Price Sensitive PS ARG-007 Shows Significant Neuroprotection in Main TBI Study | 468.54KB | 28K |
| 30/01/2025 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 441.97KB | 2.1K |